Kiely Breda, Feldman Gemma, Ryan Michael P
Department of Pharmacology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland.
Kidney Int. 2003 Mar;63(3):908-16. doi: 10.1046/j.1523-1755.2003.00804.x.
Cyclosporine A (CsA) has been shown to increase transepithelial resistance in Madin-Darby canine kidney (MDCK) cells, and the mechanism may involve altered phosphorylation of junctional proteins. In this study, we examine the effect of the extracellular signal-regulated protein kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (MAPK) pathways on the basal transepithelial resistance (TER) and on the CsA-induced increase in TER across MDCK monolayers. Here we present evidence that CsA may be mediating some of its effects through activation of the ERK 1/2 MAPK pathway.
MDCK cells were treated with CsA (4.2 micromol/L) and paracellular permeability was assessed by measuring TER. The role of the ERK 1/2 and the p38 MAPK pathways in modulating TER was investigated using the inhibitors PD98059 and U0126 for ERK 1/2 and SB203580 for p38. ERK 1/2 and p38 phosphorylation/activation was also examined by Western blot analysis.
CsA (4.2 micromol/L) increased the TER of MDCK monolayers. The ERK 1/2 inhibitor PD98059 decreased basal TER and also ameliorated the CsA-induced increase in TER. Similar results were found with the U0126 inhibitor of ERK 1/2. The p38 inhibitor SB203580 had no effect on the basal TER of the monolayers, however, SB203580 significantly augmented the CsA-induced increase in TER. CsA was shown to significantly activate ERK 1/2 and this activation by CsA was prevented by PD98059. Inhibition of the p38 pathway by SB203580 also resulted in activation of ERK 1/2 and this activation of ERK 1/2 was further enhanced by CsA. No effect of CsA or the inhibitors PD98059 or SB203580 on p38 phosphorylation was detected.
The results presented here suggest that activation of the ERK 1/2 MAPK cascade is important in the regulation of the paracellular permeability in MDCK cells. Activation of this pathway appears to be pivotal to the CsA-induced increase in TER.
已表明环孢素A(CsA)可增加麦迪逊-达比犬肾(MDCK)细胞的跨上皮电阻,其机制可能涉及连接蛋白磷酸化的改变。在本研究中,我们检测细胞外信号调节蛋白激酶(ERK)1/2和p38丝裂原活化蛋白激酶(MAPK)途径对MDCK单层细胞基础跨上皮电阻(TER)以及CsA诱导的TER增加的影响。在此我们提供证据表明CsA可能通过激活ERK 1/2 MAPK途径介导其部分作用。
用CsA(4.2微摩尔/升)处理MDCK细胞,并通过测量TER评估细胞旁通透性。使用ERK 1/2的抑制剂PD98059和U0126以及p38的抑制剂SB203580研究ERK 1/2和p38 MAPK途径在调节TER中的作用。还通过蛋白质印迹分析检测ERK 1/2和p38的磷酸化/激活情况。
CsA(4.2微摩尔/升)增加了MDCK单层细胞的TER。ERK 1/2抑制剂PD98059降低了基础TER,并改善了CsA诱导的TER增加。ERK 1/2的抑制剂U0126也得到了类似结果。p38抑制剂SB203580对单层细胞的基础TER没有影响,然而,SB203580显著增强了CsA诱导的TER增加。已表明CsA可显著激活ERK 1/2,且PD98059可阻止CsA的这种激活作用。SB203580对p38途径的抑制也导致ERK 1/2的激活,且CsA进一步增强了ERK 1/2的这种激活作用。未检测到CsA或抑制剂PD98059或SB203580对p38磷酸化有影响。
此处呈现的结果表明ERK 1/2 MAPK级联反应的激活在调节MDCK细胞的细胞旁通透性中起重要作用。该途径的激活似乎对CsA诱导的TER增加至关重要。